CHEK'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Check-Cap Ltd. CHEK'ün son çeyrekteki geliri nasıl performans gösterdi?
Check-Cap Ltd.'in gelir tahmini nedir?
Check-Cap Ltd.'in kazanç kalite puanı nedir?
Check-Cap Ltd. kazançlarını ne zaman rapor eder?
Check-Cap Ltd.'in beklenen kazançları nelerdir?
Check-Cap Ltd. kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
--
EPS (TTM)
--
Dividend yield
--
Piyasa Değeri
--
Check-Cap Ltd. nedir?
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.